SIBO recurrence after rifaximin
When eradication works for weeks and then the same picture comes back, the question is not which antimicrobial to try next. It is why the host kept permitting the overgrowth.
Why these symptoms travel together
The relapsing pattern is consistent across patients: bloating returns first, then food reactivity widens, then the systemic symptoms (fatigue, brain fog, sleep architecture collapse) come back on top. The order matters. It tells you the microbial overgrowth is downstream of a host condition that did not move during the antimicrobial round.
What standard workups usually find
A positive breath test. A short clinical response to rifaximin or a herbal protocol. Normal CBC, normal CMP, normal hs-CRP between flares. Patients are told the SIBO came back and offered another round.
What the Host Capacity Model says is happening upstream
The colonocyte runs on butyrate. Butyrate is β-oxidized in the mitochondrion and the resulting oxygen consumption keeps the colonic lumen anaerobic. Anaerobiosis is what suppresses the facultative anaerobes that overgrow in SIBO. When the colonocyte cannot generate enough ATP from butyrate, oxygen spills into the lumen, the facultative anaerobes expand, and the small bowel sees fermentation patterns that the breath test calls SIBO.
Rifaximin reduces the overgrowth. It does not restore the colonocyte. As soon as the antimicrobial pressure lifts, the same permissive environment is still there.
The labs I would want to see in a case like this
- A full CBC with attention to RDW
- hs-CRP and ferritin together, to anchor inflammation status
- An OAT looking at TCA intermediates and short-chain fatty acid metabolism
- A GI-MAP for Akkermansia, Faecalibacterium, and methanogen load
- A SIBO breath test, mostly to track trend rather than to direct therapy
Common leverage points
- Butyrate substrate, dosed during and after any antimicrobial round
- Oxygen-gradient restoration through colonocyte mitochondrial support
- Prokinetic coverage when motility is part of the picture
- Vagal tone work when the relapses cluster around stress
- Patience with timelines: substrate-level repair is a 3–6 month process
A fourth round of rifaximin will work for a few weeks. The host work is what prevents the fifth round.